Board Name | Posts By OTCchance | Post Created |
---|---|---|
ZRFY Zerify Inc | nothing to wait, he said 800k-1m | 12/08/2019 8:02:23 PM |
ZRFY Zerify Inc | Relax everyone, nothing happened, v | 12/02/2019 9:54:34 AM |
ZRFY Zerify Inc | hows the meeting went? | 11/22/2019 10:03:09 PM |
ZRFY Zerify Inc | is anybody can do live presentation (1) | 11/16/2019 12:44:00 PM |
ZRFY Zerify Inc | do you guys think OTCQB is somethin (1) | 11/08/2019 10:44:05 AM |
ZRFY Zerify Inc | I dont know like everybody doing, b (1) | 11/06/2019 9:11:28 PM |
ZRFY Zerify Inc | Reaching out to the community- acco | 10/14/2018 7:43:00 PM |
ZRFY Zerify Inc | Mark posted on twitter that court d (2) | 10/13/2018 7:05:02 PM |
ZRFY Zerify Inc | whats the next target after OTCQB? (1) | 08/08/2018 10:37:44 PM |
ZRFY Zerify Inc | can you pls send a link for the vid (1) | 01/28/2018 3:31:39 PM |
ZRFY Zerify Inc | im going to buy much more shares | 11/14/2017 10:49:25 PM |
ZRFY Zerify Inc | I dont know guys, but im totally fi | 11/14/2017 10:48:30 PM |
ZRFY Zerify Inc | I think we should see a bright side (1) | 09/06/2017 11:11:26 PM |
Recent Articles
- Amazon's Stock Forecast: Opportunities and Challenges Ahead
- Power Sector Challenges Ahead: Analyst Insights for 2025
- Analyst Insights: Apple Downgrades and Tesla Price Target Soars
- Balancing Act: European Governments Between Defense and Debt
- UBS Highlights Short-Term Challenges for U.S. Natural Gas Prices
- Mediobanca's Board Meeting to Discuss MPS's Bold Bid
- Challenges Ahead for Europe’s Space Industry: Key Insights
- China's State-Owned Enterprises Experience Modest Profit Growth
- Understanding Inflation: Money Supply, Fed Actions, and Economy
- Swiss President Predicts Future Budget Deficits of 3 Billion Francs
- Svante Partners with Speed Skating Canada to Combat Climate Change
- Understanding European Companies Facing Tariff Risks
- Bitcoin Surge: Impact on Crypto Job Market Dynamics Revealed
- LONGi Chairman Discusses Solar Innovations and Global Unity
- Strategic Collaboration Between it.com Domains and Dynadot
- it.com Domains Joins Forces with Dynadot for IT Excellence
- Key Insights from the Latest Energy Economy Research Reports
- Bangladesh Central Bank Engages Top Auditors for Investigation
- CCTV4 to Celebrate Spring Festival 2025 with Global Gala
- CCTV4 Gala Celebrates Spring Festival's Global Influence
- CSG Steps Up to Support Customer After Data Breach Incident
- Celebrate 2025 with the Unforgettable Summit Concert Experience
- Michael Saylor's Renewed Confidence in Bitcoin and Strategy
- Motive Appoints Chirag Shah CFO to Drive AI-Powered Growth
- Oracle's Strategic Move: Potential TikTok Acquisition Explained
- NAMM Expands Board with Eight New Leaders for 2025
- California Fire Foundation Launches New Initiative for Resilience
- Pfizer's BRAFTOVI and Cetuximab Show Promise in Colorectal Cancer
- Donald Trump's Biopic 'The Apprentice' Scores Oscar Nominations
- Investors Urged to Engage in Kaspi.kz Securities Legal Action
- Michael Waltz's Significant Transactions in BoodleAI Revealed
- Ontario's Doug Ford Responds Strongly to U.S. Trade Threats
- Investors Should Seek Legal Advice Following Allegations Against Western Asset Management
- Symbotic Inc. Shareholders Alert: Class Action Lawsuit Details
- Google's Strategic Efforts to Educate and Influence AI Policies
- Top Stock Performers Already Gaining Momentum in January
- Trump's Tax Plan on Tips Takes Center Stage in Las Vegas
- Micron Technology Investors Urged to Take Action on Lawsuit
- Class Action Lawsuit: Kyverna Therapeutics, Inc. Update
- Investors with Losses in Polestar Automotive Holding Should Act
- Latest Trends in Consumer Tech: AI Policy Changes and New Apps
- Global Initiative Launched to Protect Cats in U.S. National Parks
- Farizon SV Launches in Europe, Setting New Standards for EVs
- Ripple CTO Discusses XRP and Bitcoin's Circulating Supply Insights
- Large Investors Fuel Bitcoin Surge: Future Price Predictions
- Bristol Myers Squibb's Promising Results for Opdivo and Yervoy
- Natera Unveils Groundbreaking Phase III Trial Results for Colorectal Cancer
- Exelixis Unveils Promising Outcomes in Cancer Trial with Zanzalintinib
- Class Action Rights for Novo Nordisk A/S Investors Explained
- Opportunity for Investors in BioAge Labs, Inc. Class Action